Efficacy News and Research

RSS
Study investigates time-dependent efficacy of hUCB MNCs after experimental brain ischemia

Study investigates time-dependent efficacy of hUCB MNCs after experimental brain ischemia

One rule for one and one for another with diabetes

One rule for one and one for another with diabetes

Lighting the way to vascular lesion resolution

Lighting the way to vascular lesion resolution

Adjuvants underused initially, follow up needed for cancer patients in pain

Adjuvants underused initially, follow up needed for cancer patients in pain

Multiple Epo doses with hypothermia offers neonate neuroprotection

Multiple Epo doses with hypothermia offers neonate neuroprotection

EC approves Sosei’s Seebri Breezhaler to treat COPD

EC approves Sosei’s Seebri Breezhaler to treat COPD

New insights on global fight to prevent cancers

New insights on global fight to prevent cancers

Crizotinib effectively treats patients with ALK-positive lung cancer

Crizotinib effectively treats patients with ALK-positive lung cancer

New trial results on pazopanib and temsirolimus have important implications for patients with RCC

New trial results on pazopanib and temsirolimus have important implications for patients with RCC

Sorafenib does not improve overall survival among patients with NSCLC

Sorafenib does not improve overall survival among patients with NSCLC

Drug combinations show promise against metastatic melanoma

Drug combinations show promise against metastatic melanoma

Synta announces results from ganetespib Phase 2b trial on NSCLC

Synta announces results from ganetespib Phase 2b trial on NSCLC

New trial data shows improvements in treatment of esophageal and gastrointestinal cancers

New trial data shows improvements in treatment of esophageal and gastrointestinal cancers

Cardiac Dimensions commences commercialization of CARILLON mitral contour system in Europe

Cardiac Dimensions commences commercialization of CARILLON mitral contour system in Europe

MicroDose completes third and final MDT-637 Phase 1 study on RSV infection

MicroDose completes third and final MDT-637 Phase 1 study on RSV infection

AVEO submits tivozanib NDA with FDA for treatment of advanced renal cell carcinoma

AVEO submits tivozanib NDA with FDA for treatment of advanced renal cell carcinoma

U.S. Pharmacopeial announces winners of 2012-13 Global Fellowship awards

U.S. Pharmacopeial announces winners of 2012-13 Global Fellowship awards

Researchers discover way to detect and eliminate troublemaking stem cells

Researchers discover way to detect and eliminate troublemaking stem cells

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

EC approves Janssen’s DACOGEN for treatment of de novo acute myeloid leukaemia

EC approves Janssen’s DACOGEN for treatment of de novo acute myeloid leukaemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.